Every phase of clinical trial design at is chiefly concerned with demonstrating the safety and efficacy of the treatment being developed. On the path to product full commercialization countless complications can and often do arise. Matrix Healthcare Solutions (MHS) specializes in clinical trial design from Phase 1 to Phase 3b, acting as a trusted partner whether stakeholders are initially characterizing proprietary assets or determining the quality of life and marketing implications of novel treatments.

We work closely with Sponsors and Clinical Research Organisations (CROs) to guarantee that product development is appropriately managed to secure both the well-being of all patients and the interests of investors. If you need support in Phase 1 – 3b clinical trial design, simply contact a member of the MHS management team today.